期刊文献+

17β-雌二醇经人CYP1B1代谢产物研究 被引量:1

Analysis of 17β-Estradiol Metabolites via Human CYP1B1 by HPLC-ECD
下载PDF
导出
摘要 目的:采用高效液相色谱与电化学检测器联用(HPLC-ECD)法研究17β-雌二醇经人细胞色素酶CYP1B1亚酶的代谢产物及各产物的生成速率。方法:色谱柱Mightysil RP-18GP(250 mm×3.0 mm,5μm)、柱温40℃,电化学检测器E=+900m V,流动相采用0.5%Na H_2PO_4(p H 3.0)和甲醇混合溶液(45∶55),流速0.5 ml﹒min^(-1),进样量为5μl。结果:HPLC-ECD法检测17β-雌二醇经CYP1B1代谢产物为4-OH-E_2,伴有少量2-OH-E_2。同浓度雌激素E_2经CYP1B1代谢生成4-OH-E_2的平均速率是2-OH-E_2的约5倍。结论:CYP1B1催化17β-雌二醇基于NADPH代谢的羟基化位点主要是4位。 Objective: To study the metabolites of 17β-estradiol via human cytochrome enzyme CYP! B1 and analyze the genera- tion rate of products by a high performance liquid chromatography coupled with electrochemical detector (HPLC-ECD) method, neth- otis: A Mightysil RP-18GP (250 mm×3.0mm,5μm) column was used at the temperature of 40℃. The electrochemical detector with E = + 900 mV was applied, the mobile phase was 0.5% NaH2PO4(pH 3.0) and methanol (45: 55), the flow rate was 0.5 ml mm-1 , and the injection volume was 5 μl. Results: The main metabolite was 4-OH-E2 accompanied with a little of 2-OH-E2. The average hydroxylation rate of 4-OH-E2 was about five times as much as that of 2-OH-E2 at the same concentration of estrogen E2 me- tabolized via CYP1B1. Conclusion: Taken together, CYP1 B1 catalyzed hydroxylation sites of 17-beta estradiol based on NADPH me- tabolism are really 4.
出处 《中国药师》 CAS 2018年第1期58-61,共4页 China Pharmacist
基金 黑龙江中医药大学科研基金项目(编号:201722) 黑龙江省大学生创新创业训练计划项目(编号:201710228024) 黑龙江省自然科学基金项目(编号:H2015041)
关键词 雌二醇 代谢 高效液相色谱电化学法 肿瘤 Estrogen Metabolism HPLC-ECD Tumor Estrogen Metabolism HPLC-ECD Tumor
  • 相关文献

参考文献2

二级参考文献53

  • 1赵玉婵,段春梅,曹卫红,张秀花,赵金梅,李新兵.微粉化17—β雌二醇阴道片剂对绝经后女性生活质量的影响[J].现代保健(医学创新研究),2007(08Z):139-140. 被引量:2
  • 2中华医学会妇产科学分会绝经学组.绝经过渡期和绝经后激素补充治疗临床应用指南.中华妇产科杂志,2010,45(7):635-637.
  • 3SANTEN R J. Effect of endocrine therapies on bone in breast cancer patients [ J ]. Clin Endocrinnol Metab, 2011,96 ( 2 ) : 308-319.
  • 4OTSSUKA I,TAKAHASHI S,OUCH! K. Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients [ J ]. Gan To Kagaku Ryoho ,2010,37 (2) :279-283.
  • 5MOURITS M J,TEN H,VON D,et al. The effects of tamo- xifen on proliferation and steroid receptor expression in postmenopausal endometrium [ J ]. J Chin Pathol, 2002,55(7) :514-519.
  • 6SCHMIDT D. Changesin the endometrium after tamoxifen therapy [ J]. Pathologe,2006,27( 1 ) :27-32.
  • 7WILDER J L, SHAJAHAN S, KHATrAR N H, et al. Tam- oxifen associatd malignant endometrial tumors, pathologic features and expression of hormone receptors estrogen- alpha, estrogen-beta and progesterone: a case controlled study[J].]. Gynecol Oncol,2004,92(2):553-558.
  • 8KIM M R, KIM A, JO M Y, et al. High frenquency of endometrial polyps in endometriosis [ J ]. J Am Assoc Gynecol Laparosc ,2003,10( 1 ) :46-48.
  • 9WHINEY C W, BRUNETrO V L, ZAINO R J, et al. Phase II study of medroxyprofesterone acetate plus tamoxifen in advanced endometrial carcinoma: a gynecologic oncology group study [ J ]. Gynecol Oncol,2004,91 ( 1 ) : 10-14.
  • 10NILSSON C, LAHTEENMAKI P, LUUKKAINEN T, et al. Sustained intrauterine release of levonorgestrel over five years [ J]. Fertil Steril, 1986,45 (6) :805-807.

共引文献19

同被引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部